Pain Medicine, Interventional Pain Medicine · West Columbia, SC
NPI
1194770115
Since 2006
Specialty
Pain Medicine, Interventional Pain Medicine
Code 208VP0014X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
3227 Sunset Blvd # F, Suite 102
West Columbia, SC, 29169
Phone (803) 724-2336
Groups this clinician bills Medicare through
Medicare paid, 2024
$299K
5,999 services
Medicare patients, 2024
332
Average age 70
Drug cost, 2024
$756K
4,224 prescriptions
Company payments, 2025
$657
From 7 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Kenneth R Grosslight was code 99214 (office e&m - established), 2,247 times for 312 patients. In total Kenneth R Grosslight billed 5,999 services in 47 codes, and Medicare paid $299K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-07-24.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 2,247 | 312 | $86.52 | $194K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 1,161 | 76 | $0.09 | $101 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 865 | 241 | $12.61 | $11K |
| 99213 Office E&M - Established | Office | 405 | 205 | $50.21 | $20K |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 341 | 62 | $0.74 | $251 |
| 80305 Drug Tests | Office | 301 | 206 | $11.94 | $3,593 |
| Q9966 Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | Office | 91 | 55 | $0.28 | $25.68 |
| 20611 Joint Injection | Office | 60 | 37 | $66.76 | $4,006 |
| 64636 Destruction by Neurolytic Agent - Back | Office | 58 | 25 | $172.63 | $10K |
| 62323 Nerve Block Injection - Back | Office | 52 | 37 | $181.68 | $9,447 |
| 76942 Ultrasound - Nonspecific | Office | 34 | 15 | $27.69 | $941 |
| 64493 Nerve Block Injection - Back | Office | 33 | 20 | $122.17 | $4,032 |
| 64494 Nerve Block Injection - Back | Office | 33 | 20 | $64.86 | $2,140 |
| 64635 Destruction by Neurolytic Agent - Back | Office | 29 | 25 | $311.04 | $9,020 |
| 99204 Office E&M - New | Office | 22 | 22 | $103.00 | $2,266 |
By year: 2022 $288K for 6,577 services; 2023 $254K for 5,973 services; 2024 $299K for 5,999 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 80305 Drug Tests | 301 | 206 | $11.94 | $3,593 |
Medicare prescription drug claims, 2024
In 2024, the drug Kenneth R Grosslight prescribed most often to Medicare patients was Oxycodone Hcl, with 621 prescriptions and refills. In total Kenneth R Grosslight wrote 4,224 Medicare prescriptions that cost $756K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Oxycodone Hcl Generic | 621 | 621 | 157 | $20K |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 614 | 614 | 171 | $166K |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 488 | 488 | 127 | $17K |
| Morphine Sulfate Er Morphine Sulfate | 468 | 468 | 118 | $14K |
| Gabapentin Generic | 264 | 302 | 70 | $6,251 |
| Pregabalin Generic | 162 | 186 | 50 | $3,906 |
| Amitriptyline Hcl Generic | 154 | 164 | 38 | $1,158 |
| Meloxicam Generic | 151 | 165 | 39 | $457 |
| Tizanidine Hcl Generic | 110 | 150 | 47 | $2,515 |
| Xtampza Er Oxycodone Myristate | 94 | 94 | 27 | $86K |
| Hydromorphone Hcl Generic | 64 | 64 | 17 | $2,181 |
| Cyclobenzaprine Hcl Generic | 62 | 74 | 20 | $679 |
| Relistor Methylnaltrexone Bromide | 52 | 52 | 11 | $122K |
| Oxycontin Oxycodone Hcl | 44 | 44 | 11 | $43K |
| Lidocaine Generic | 38 | 50 | Under 11 | $4,698 |
Brand drugs: 484 claims; generic drugs: 3,740 claims; opioid claims: 2,646.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Kenneth R Grosslight $657 ($657 in general payments such as food, travel and fees) from 7 companies. The largest payer was Forte Bio-Pharma LLC with $401.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.